Vivek Tiwari, Elena V Daoud, Kimmo J Hatanpaa, Ang Gao, Song Zhang, Zhongxu An, Sandeep K Ganji, Jack M Raisanen, Cheryl M Lewis, Pegah Askari, Jeannie Baxter, Michael Levy, Ivan Dimitrov, Binu P Thomas, Marco C Pinho, Christopher J Madden, Edward Pan, Toral R Patel, Ralph J DeBerardinis, A Dean Sherry, Bruce E Mickey, Craig R Malloy, Elizabeth A Maher, Changho Choi
BACKGROUND: High-grade gliomas likely remodel the metabolic machinery to meet the increased demands for amino acids and nucleotides during rapid cell proliferation. Glycine, a non-essential amino acid and intermediate of nucleotide biosynthesis, may increase with proliferation. Non-invasive measurement of glycine by magnetic resonance spectroscopy (MRS) was evaluated as an imaging biomarker for assessment of tumor aggressiveness. METHODS: We measured glycine, 2-hydroxyglutarate (2HG), and other tumor-related metabolites in 35 glioma patients using an MRS sequence tailored for co-detection of glycine and 2HG in gadolinium-enhancing and non-enhancing tumor regions on 3T MRI...
July 7, 2020: Neuro-oncology